Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT04921189

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04921189
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04921189. Randomized; double masking; primary purpose treatment. Start 2021-12-31 (actual); primary completion 2024-12-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors
Condition
Out-Of-Hospital Cardiac Arrest
Condition
Postcardiac Arrest Syndrome
Intervention (Drug)
The combined supplement of Ascorbic acid, Thiamine, and Cortisol
Intervention (Drug)
Placebo
Lead sponsor
Asan Medical Center (class: other)
Collaborator
Seoul St. Mary's Hospital (class: other)
Collaborator
Wonju Severance Christian Hospital (class: other)
Collaborator
Samsung Changwon Hospital (class: other)
Collaborator
Samsung Medical Center (class: other)
Collaborator
Chung-Ang University (class: other)
Collaborator
Hanyang University (class: other)
Collaborator
Ewha Womans University (class: other)
Collaborator
Hanil General Hospital (class: not stated)

Record details

Record id
cardio:ct-nct04921189
Content hash
3267b75b34a87723106c7d5db52e6796166e61e150991ab78efe16737c56d8f8